Focus on Apremilast in Dermatology - The Indian Scenario |
Conferences
eMediNexus Coverage from: 
Focus on Apremilast in Dermatology - The Indian Scenario
Dr DA Satish, Bengaluru,  22 January 2019
Coronavirus Live Count Map India

remove_red_eye 948 Views
COVID-19 Vaccine Updates

Coronavirus Protocols

#Dermatology

1 Read Comments                

Apremilast is a promising new small molecule and a valuable addition to the therapeutic armamentarium in psoriasis.It can be used as both monotherapy and combination therapy and when patient is intolerant to other systemic therapies or has less response to other therapies.As combination therapy it can be used with all agents-methotrexate, cyclosporine, acitretin, phototherapy and biologicals.Apremilast gives good response in difficult to treat psoriasis like palmoplantar, nail and scalp psoriasi...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now